- Home
- ALX vs ATRC Comparison
ALX vs ATRC Comparison
Compare ALX & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALX
- ATRC
- Stock Information
- Founded
- ALX 1928
- ATRC 2000
- Country
- ALX United States
- ATRC United States
- Employees
- ALX N/A
- ATRC N/A
- Industry
- ALX Real Estate Investment Trusts
- ATRC Medical/Dental Instruments
- Sector
- ALX Real Estate
- ATRC Health Care
- Exchange
- ALX Nasdaq
- ATRC Nasdaq
- Market Cap
- ALX 1.1B
- ATRC 1.1B
- IPO Year
- ALX N/A
- ATRC 2005
- Fundamental
- Price
- ALX $190.89
- ATRC $39.50
- Analyst Decision
- ALX Sell
- ATRC Strong Buy
- Analyst Count
- ALX 1
- ATRC 9
- Target Price
- ALX $125.00
- ATRC $43.00
- AVG Volume (30 Days)
- ALX 13.4K
- ATRC 537.2K
- Earning Date
- ALX 02-10-2025
- ATRC 02-12-2025
- Dividend Yield
- ALX 9.43%
- ATRC N/A
- EPS Growth
- ALX N/A
- ATRC N/A
- EPS
- ALX 9.25
- ATRC N/A
- Revenue
- ALX $233,399,000.00
- ATRC $447,573,000.00
- Revenue This Year
- ALX N/A
- ATRC $17.75
- Revenue Next Year
- ALX N/A
- ATRC $13.44
- P/E Ratio
- ALX $21.11
- ATRC N/A
- Revenue Growth
- ALX 8.52
- ATRC 17.56
- 52 Week Low
- ALX $184.76
- ATRC $18.94
- 52 Week High
- ALX $251.63
- ATRC $41.04
- Technical
- Relative Strength Index (RSI)
- ALX 38.56
- ATRC 71.95
- Support Level
- ALX $184.76
- ATRC $31.00
- Resistance Level
- ALX $196.39
- ATRC $34.11
- Average True Range (ATR)
- ALX 4.22
- ATRC 1.84
- MACD
- ALX 0.93
- ATRC 0.93
- Stochastic Oscillator
- ALX 36.47
- ATRC 86.15
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.